课题基金 / 基金详情

GABA-ERGIC MECHANISMS INFLUENCING VASOPRESSIN RELEASE

GABA-ERGIC MECHANISMS INFLUENCING VASOPRESSIN RELEASE
影响加压素释放的 GABA 能机制
批准号:
3344556
负责人:
Joseph R Haywood
金额:
$5.54万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1988-06-30

项目摘要

项目成果

Joseph R Haywood的其他基金

相似基金

相关文献

中文摘要
翻译
这个实验室以前的工作已经表明,GABA可以阻断渗透压 刺激后叶加压素的释放。将在以下方面测试的假设 这一建议是GABA或药物激活的 内源性前脑GABA能系统对两者的干扰作用 渗透压和压力感受器刺激的加压素释放机制。一个 将要检验的推论假设是GABA断言一种补药 抑制加压素系统作为压力感受器反射途径的一部分。 在渗透压和压力感受器激活的加压素释放过程中,加压素 动脉压、心率、心输出量和 将监测总外周阻力。限制分发的步骤 将GABA集中注射到前脑,冷奶油塞将是 放置在后第三脑室。第一项研究将检测GABA 与渗透刺激的相互作用。急性无肾大鼠将被注入 高渗氯化钠刺激渗透性激活的加压素 放手。在第二项研究中,压力感受器介导的加压素释放 将由卡托普利(A)顺序给药刺激 肾素-血管紧张素系统拮抗剂)和神经节阻滞剂(a 交感神经系统拮抗剂)以降低动脉压。在这两个地方 在这些研究中,GABA,一种GABA(硝酸)的摄取抑制剂,或 将给予GABA的代谢抑制剂(伽马-乙烯基GABA)来评估 对血浆加压素水平和全身血流动力学的影响。第三 研究将集中在GABA在紧张性抑制加压素中的作用 通过压力反射机制释放。局部注射GABA 拮抗剂荷包牡丹碱进入视上核,将用于 调查此操作。这些研究将大大有助于 GABA能系统在调节加压素中的作用 放手。
英文摘要
Previous work in this laboratory has shown that GABA blocks the osmotic stimulation of vasopressin release. The hypothesis that will be tested in this proposal is that GABA or the pharmacological activation of the endogenous forebrain GABAergic system is capable of interfering with both osmotic and baroreceptor stimulated vasopressin release mechanisms. A corollary hypothesis that will be examined is that GABA asserts a tonic inhibition on the vasopressin system as part of the baroreflex pathway. During osmotic and baroreceptor activated vasopressin release, vasopressin levels and changes in arterial pressure, heart rate, cardiac output and total peripheral resistance will be monitored. To limit the distribution of centrally administered GABA to the forebrain, a cold cream plug will be placed in the posterior third ventricle. The first study will examine GABA interactions with osmotic stimuli. Acutely anephric rats will be infused with hypertonic sodium chloride to stimulate osmotic activated vasopressin release. In the second study, baroreceptor mediated vasopressin release will be stimulated with sequential administration of captopril (a renin-angiotensin system antagonist) and a ganglionic blocking agent (a sympathetic nervous system antagonist) to lower arterial pressure. In both of these studies, GABA, an uptake inhibitor of GABA (nipecotic acid), or a metabolism inhibitor of GABA (Gamma-vinyl GABA) will be given to assess the effect on plasma vasopressin levels and systemic hemodynamics. The third study will focus on the role of GABA in the tonic inhibition of vasopressin release through a baroreflex mechanism. Local injections of the GABA antagonist, bicuculline, into the supraoptic nucleus, will be used to investigate this action. These studies will contribute significantly to an understanding of the role of the GABAergic system in modulating vasopressin release.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MSU Clinical Center Animal Facility HVAC Upgrade
  • 批准号:
    8185686
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2012
  • 负责人:
    Joseph R Haywood
  • 依托单位:
MSU-Short Course in Integrative Pharmacology
  • 批准号:
    6918315
  • 项目类别:
  • 资助金额:
    $18.58万
  • 财政年份:
    2005
  • 负责人:
    Joseph R Haywood
  • 依托单位:
MSU-Short Course in Integrative Pharmacology
  • 批准号:
    7112930
  • 项目类别:
  • 资助金额:
    $18.69万
  • 财政年份:
    2005
  • 负责人:
    Joseph R Haywood
  • 依托单位:
MSU-Short Course in Integrative Pharmacology
  • 批准号:
    7586804
  • 项目类别:
  • 资助金额:
    $12.13万
  • 财政年份:
    2005
  • 负责人:
    Joseph R Haywood
  • 依托单位:
海外基金